Atypical Endometrial Hyperplasia Clinical Trials

26 clinical trials for Atypical Endometrial Hyperplasia across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Endometrial Cancer Vaginal Fluid Specimen Collection Study — RECRUITING
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia — RECRUITING · PHASE2
• Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer — RECRUITING
• Intrauterine Injection of Type III Collage in FST of EC/AEH — RECRUITING · PHASE2
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients — RECRUITING · PHASE2
• GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients — RECRUITING · PHASE2
• Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer — RECRUITING
• Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC — RECRUITING · PHASE2
• Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia — NOT_YET_RECRUITING · PHASE2
• SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer — NOT_YET_RECRUITING · PHASE4
• Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy — ACTIVE_NOT_RECRUITING · PHASE2
• Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia — COMPLETED · PHASE2
• Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Ultrasound and Histology in AEH and Early EEC Treated Conservatively — NOT_YET_RECRUITING
• Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia — WITHDRAWN · PHASE2
• Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia — TERMINATED · PHASE2
• Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia — COMPLETED · PHASE2
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia — OTHER · PHASE2
• CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells — OTHER · NA
• Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia — COMPLETED · PHASE2
• LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia — COMPLETED · PHASE2
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate — COMPLETED · PHASE2
• Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer — WITHDRAWN · PHASE2
• Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women — COMPLETED · PHASE3

Refine this search